Zobrazeno 1 - 9
of 9
pro vyhledávání: '"Fanchi LF"'
Autor:
Simnica D; Department of Internal Medicine IV, Oncology/Hematology, Martin-Luther-University Halle-Wittenberg, Halle (Saale), Germany., Smits M; Department of Medical Oncology, Radboud University Medical Center, Nijmegen, the Netherlands., Willscher E; Department of Internal Medicine IV, Oncology/Hematology, Martin-Luther-University Halle-Wittenberg, Halle (Saale), Germany., Fanchi LF; ENPICOM B.V., 's-Hertogenbosch, the Netherlands., Kloots ISH; Department of Medical Oncology, Radboud University Medical Center, Nijmegen, the Netherlands., van Oort I; Department of Medical Oncology, Radboud University Medical Center, Nijmegen, the Netherlands., Gerritsen W; Department of Medical Oncology, Radboud University Medical Center, Nijmegen, the Netherlands., Mehra N; Department of Medical Oncology, Radboud University Medical Center, Nijmegen, the Netherlands., Binder M; Department of Internal Medicine IV, Oncology/Hematology, Martin-Luther-University Halle-Wittenberg, Halle (Saale), Germany.
Publikováno v:
JCO precision oncology [JCO Precis Oncol] 2020 Nov; Vol. 4, pp. 1374-1385.
Autor:
Prota G; MRC Human Immunology Unit, Weatherall Institute of Molecular Medicine, University of Oxford, Oxford, United Kingdom. gennaro.prota@rdm.ox.ac.uk., Gileadi U; MRC Human Immunology Unit, Weatherall Institute of Molecular Medicine, University of Oxford, Oxford, United Kingdom., Rei M; MRC Human Immunology Unit, Weatherall Institute of Molecular Medicine, University of Oxford, Oxford, United Kingdom., Lechuga-Vieco AV; MRC Human Immunology Unit, Weatherall Institute of Molecular Medicine, University of Oxford, Oxford, United Kingdom.; Centro Nacional de Investigaciones Cardiovasculares Carlos III, Madrid, Spain.; Ciber de Enfermedades Respiratorias (CIBERES), Madrid, Spain., Chen JL; MRC Human Immunology Unit, Weatherall Institute of Molecular Medicine, University of Oxford, Oxford, United Kingdom., Galiani S; MRC Human Immunology Unit, Weatherall Institute of Molecular Medicine, University of Oxford, Oxford, United Kingdom., Bedard M; MRC Human Immunology Unit, Weatherall Institute of Molecular Medicine, University of Oxford, Oxford, United Kingdom., Lau VWC; MRC Human Immunology Unit, Weatherall Institute of Molecular Medicine, University of Oxford, Oxford, United Kingdom., Fanchi LF; Division of Molecular Oncology and Immunology, Oncode Institute, The Netherlands Cancer Institute, Amsterdam, the Netherlands., Artibani M; Ovarian Cancer Cell Laboratory, Weatherall Institute of Molecular Medicine, University of Oxford, Oxford, United Kingdom.; Nuffield Department of Women's and Reproductive Health, University of Oxford, Women's Centre, John Radcliffe Hospital, United Kingdom., Hu Z; Ovarian Cancer Cell Laboratory, Weatherall Institute of Molecular Medicine, University of Oxford, Oxford, United Kingdom.; Nuffield Department of Women's and Reproductive Health, University of Oxford, Women's Centre, John Radcliffe Hospital, United Kingdom., Gordon S; Sir William Dunn School of Pathology, University of Oxford, Oxford, United Kingdom.; Chang Gung University, Graduate Institute of Biomedical Sciences, College of Medicine, Taoyuan City, Taiwan., Rehwinkel J; MRC Human Immunology Unit, Weatherall Institute of Molecular Medicine, University of Oxford, Oxford, United Kingdom., Enríquez JA; Centro Nacional de Investigaciones Cardiovasculares Carlos III, Madrid, Spain.; Ciber de Fragilidad y Envejecimiento Saludable (CIBERFES), Madrid, Spain., Ahmed AA; Ovarian Cancer Cell Laboratory, Weatherall Institute of Molecular Medicine, University of Oxford, Oxford, United Kingdom.; Nuffield Department of Women's and Reproductive Health, University of Oxford, Women's Centre, John Radcliffe Hospital, United Kingdom., Schumacher TN; Division of Molecular Oncology and Immunology, Oncode Institute, The Netherlands Cancer Institute, Amsterdam, the Netherlands., Cerundolo V; MRC Human Immunology Unit, Weatherall Institute of Molecular Medicine, University of Oxford, Oxford, United Kingdom.
Publikováno v:
Cancer immunology research [Cancer Immunol Res] 2020 May; Vol. 8 (5), pp. 685-697. Date of Electronic Publication: 2020 Mar 23.
Autor:
Chalabi M; Gastrointestinal Oncology, Netherlands Cancer Institute, Amsterdam, the Netherlands. m.chalabi@nki.nl.; Molecular Oncology and Immunology, Netherlands Cancer Institute, Amsterdam, the Netherlands. m.chalabi@nki.nl.; Medical Oncology, Netherlands Cancer Institute, Amsterdam, the Netherlands. m.chalabi@nki.nl., Fanchi LF; Molecular Oncology and Immunology, Netherlands Cancer Institute, Amsterdam, the Netherlands.; Oncode Institute, Utrecht, the Netherlands., Dijkstra KK; Molecular Oncology and Immunology, Netherlands Cancer Institute, Amsterdam, the Netherlands.; Oncode Institute, Utrecht, the Netherlands., Van den Berg JG; Pathology, Netherlands Cancer Institute, Amsterdam, the Netherlands., Aalbers AG; Surgical Oncology, Netherlands Cancer Institute, Amsterdam, the Netherlands., Sikorska K; Biometrics, Netherlands Cancer Institute, Amsterdam, the Netherlands., Lopez-Yurda M; Biometrics, Netherlands Cancer Institute, Amsterdam, the Netherlands.; Princess Máxima Center for Pediatric Oncology, Utrecht, the Netherlands., Grootscholten C; Gastrointestinal Oncology, Netherlands Cancer Institute, Amsterdam, the Netherlands., Beets GL; Surgical Oncology, Netherlands Cancer Institute, Amsterdam, the Netherlands.; GROW School for Oncology and Developmental Biology, Maastricht University, Maastricht, the Netherlands., Snaebjornsson P; Pathology, Netherlands Cancer Institute, Amsterdam, the Netherlands., Maas M; Radiology, Netherlands Cancer Institute, Amsterdam, the Netherlands., Mertz M; Bioimaging Facility, Netherlands Cancer Institute, Amsterdam, the Netherlands., Veninga V; Molecular Oncology and Immunology, Netherlands Cancer Institute, Amsterdam, the Netherlands.; Oncode Institute, Utrecht, the Netherlands., Bounova G; Oncode Institute, Utrecht, the Netherlands.; Molecular Carcinogenesis, Netherlands Cancer Institute, Amsterdam, the Netherlands., Broeks A; Core Facility Molecular Pathology & Biobanking, Netherlands Cancer Institute, Amsterdam, the Netherlands., Beets-Tan RG; GROW School for Oncology and Developmental Biology, Maastricht University, Maastricht, the Netherlands.; Radiology, Netherlands Cancer Institute, Amsterdam, the Netherlands., de Wijkerslooth TR; Gastrointestinal Oncology, Netherlands Cancer Institute, Amsterdam, the Netherlands., van Lent AU; Gastroenterology & Hepatology, Onze Lieve Vrouwe Gasthuis, Amsterdam, the Netherlands., Marsman HA; Surgery, Onze Lieve Vrouwe Gasthuis, Amsterdam, the Netherlands., Nuijten E; Biometrics, Netherlands Cancer Institute, Amsterdam, the Netherlands., Kok NF; Surgical Oncology, Netherlands Cancer Institute, Amsterdam, the Netherlands., Kuiper M; Gastrointestinal Oncology, Netherlands Cancer Institute, Amsterdam, the Netherlands., Verbeek WH; Gastrointestinal Oncology, Netherlands Cancer Institute, Amsterdam, the Netherlands., Kok M; Medical Oncology, Netherlands Cancer Institute, Amsterdam, the Netherlands.; Tumor Biology & Immunology, Netherlands Cancer Institute, Amsterdam, the Netherlands., Van Leerdam ME; Gastrointestinal Oncology, Netherlands Cancer Institute, Amsterdam, the Netherlands., Schumacher TN; Molecular Oncology and Immunology, Netherlands Cancer Institute, Amsterdam, the Netherlands.; Oncode Institute, Utrecht, the Netherlands., Voest EE; Gastrointestinal Oncology, Netherlands Cancer Institute, Amsterdam, the Netherlands. e.voest@nki.nl.; Molecular Oncology and Immunology, Netherlands Cancer Institute, Amsterdam, the Netherlands. e.voest@nki.nl.; Oncode Institute, Utrecht, the Netherlands. e.voest@nki.nl., Haanen JB; Molecular Oncology and Immunology, Netherlands Cancer Institute, Amsterdam, the Netherlands.; Medical Oncology, Netherlands Cancer Institute, Amsterdam, the Netherlands.
Publikováno v:
Nature medicine [Nat Med] 2020 Apr; Vol. 26 (4), pp. 566-576. Date of Electronic Publication: 2020 Apr 06.
Autor:
Cattaneo CM; Department of Molecular Oncology and Immunology, The Netherlands Cancer Institute, Antoni van Leeuwenhoek Hospital, Amsterdam, the Netherlands.; Oncode Institute, Utrecht, the Netherlands., Dijkstra KK; Department of Molecular Oncology and Immunology, The Netherlands Cancer Institute, Antoni van Leeuwenhoek Hospital, Amsterdam, the Netherlands.; Oncode Institute, Utrecht, the Netherlands., Fanchi LF; Department of Molecular Oncology and Immunology, The Netherlands Cancer Institute, Antoni van Leeuwenhoek Hospital, Amsterdam, the Netherlands., Kelderman S; Department of Molecular Oncology and Immunology, The Netherlands Cancer Institute, Antoni van Leeuwenhoek Hospital, Amsterdam, the Netherlands., Kaing S; Department of Molecular Oncology and Immunology, The Netherlands Cancer Institute, Antoni van Leeuwenhoek Hospital, Amsterdam, the Netherlands.; Oncode Institute, Utrecht, the Netherlands., van Rooij N; Department of Molecular Oncology and Immunology, The Netherlands Cancer Institute, Antoni van Leeuwenhoek Hospital, Amsterdam, the Netherlands., van den Brink S; Oncode Institute, Utrecht, the Netherlands.; Hubrecht Institute for Developmental Biology and Stem Cell Research-KNAW & University Medical Center Utrecht, Utrecht, the Netherlands., Schumacher TN; Department of Molecular Oncology and Immunology, The Netherlands Cancer Institute, Antoni van Leeuwenhoek Hospital, Amsterdam, the Netherlands.; Oncode Institute, Utrecht, the Netherlands., Voest EE; Department of Molecular Oncology and Immunology, The Netherlands Cancer Institute, Antoni van Leeuwenhoek Hospital, Amsterdam, the Netherlands. e.voest@nki.nl.; Oncode Institute, Utrecht, the Netherlands. e.voest@nki.nl.
Publikováno v:
Nature protocols [Nat Protoc] 2020 Jan; Vol. 15 (1), pp. 15-39. Date of Electronic Publication: 2019 Dec 18.
Autor:
Simnica D; Department of Internal Medicine IV, Oncology and Hematology, Martin-Luther-University Halle-Wittenberg, Halle, Germany., Schliffke S; Department of Oncology and Hematology, BMT With Section Pneumology, University Cancer Center Hamburg, University Medical Center Hamburg-Eppendorf (UKE), Hamburg, Germany., Schultheiß C; Department of Internal Medicine IV, Oncology and Hematology, Martin-Luther-University Halle-Wittenberg, Halle, Germany., Bonzanni N; ENPICOM B.V., 's-Hertogenbosch, Netherlands., Fanchi LF; ENPICOM B.V., 's-Hertogenbosch, Netherlands., Akyüz N; Department of Oncology and Hematology, BMT With Section Pneumology, University Cancer Center Hamburg, University Medical Center Hamburg-Eppendorf (UKE), Hamburg, Germany., Gösch B; Department of Oncology and Hematology, BMT With Section Pneumology, University Cancer Center Hamburg, University Medical Center Hamburg-Eppendorf (UKE), Hamburg, Germany., Casar C; Department of Gastroenterology With Sections Infectious and Tropical Diseases, University Medical Center Hamburg-Eppendorf (UKE), Hamburg, Germany.; Bioinformatics Core, University Medical Center Hamburg-Eppendorf (UKE), Hamburg, Germany., Thiele B; Department of Oncology and Hematology, BMT With Section Pneumology, University Cancer Center Hamburg, University Medical Center Hamburg-Eppendorf (UKE), Hamburg, Germany., Schlüter J; Department of Oncology and Hematology, BMT With Section Pneumology, University Cancer Center Hamburg, University Medical Center Hamburg-Eppendorf (UKE), Hamburg, Germany., Lohse AW; Department of Gastroenterology With Sections Infectious and Tropical Diseases, University Medical Center Hamburg-Eppendorf (UKE), Hamburg, Germany., Binder M; Department of Internal Medicine IV, Oncology and Hematology, Martin-Luther-University Halle-Wittenberg, Halle, Germany.
Publikováno v:
Frontiers in immunology [Front Immunol] 2019 Aug 21; Vol. 10, pp. 1897. Date of Electronic Publication: 2019 Aug 21 (Print Publication: 2019).
Autor:
Simnica D; Department of Internal Medicine IV, Oncology/Hematology, Martin-Luther-University Halle-Wittenberg, Halle (Saale), Germany., Akyüz N; Department of Oncology and Hematology, BMT with section Pneumology, University Cancer Center Hamburg, University Medical Center Hamburg-Eppendorf (UKE), Hamburg, Germany., Schliffke S; Department of Oncology and Hematology, BMT with section Pneumology, University Cancer Center Hamburg, University Medical Center Hamburg-Eppendorf (UKE), Hamburg, Germany., Mohme M; Department of Neurosurgery, University Medical Center Hamburg-Eppendorf (UKE), Hamburg, Germany., V Wenserski L; Department of Internal Medicine IV, Oncology/Hematology, Martin-Luther-University Halle-Wittenberg, Halle (Saale), Germany., Mährle T; Department of Oncology and Hematology, BMT with section Pneumology, University Cancer Center Hamburg, University Medical Center Hamburg-Eppendorf (UKE), Hamburg, Germany., Fanchi LF; ENPICOM B.V., 's-Hertogenbosch, The Netherlands., Lamszus K; Department of Neurosurgery, University Medical Center Hamburg-Eppendorf (UKE), Hamburg, Germany., Binder M; Department of Internal Medicine IV, Oncology/Hematology, Martin-Luther-University Halle-Wittenberg, Halle (Saale), Germany.
Publikováno v:
Oncoimmunology [Oncoimmunology] 2019 Jul 25; Vol. 8 (11), pp. e1644110. Date of Electronic Publication: 2019 Jul 25 (Print Publication: 2019).
Autor:
Scheper W; Division of Molecular Oncology & Immunology, Oncode Institute, the Netherlands Cancer Institute, Amsterdam, the Netherlands., Kelderman S; Division of Molecular Oncology & Immunology, the Netherlands Cancer Institute, Amsterdam, the Netherlands., Fanchi LF; Division of Molecular Oncology & Immunology, Oncode Institute, the Netherlands Cancer Institute, Amsterdam, the Netherlands., Linnemann C; Division of Molecular Oncology & Immunology, the Netherlands Cancer Institute, Amsterdam, the Netherlands., Bendle G; Division of Molecular Oncology & Immunology, the Netherlands Cancer Institute, Amsterdam, the Netherlands., de Rooij MAJ; Division of Molecular Oncology & Immunology, the Netherlands Cancer Institute, Amsterdam, the Netherlands., Hirt C; Department of Biomedicine, University of Basel, Basel, Switzerland., Mezzadra R; Division of Molecular Oncology & Immunology, Oncode Institute, the Netherlands Cancer Institute, Amsterdam, the Netherlands., Slagter M; Division of Molecular Oncology & Immunology, Oncode Institute, the Netherlands Cancer Institute, Amsterdam, the Netherlands.; Division of Molecular Carcinogenesis, Oncode Institute, the Netherlands Cancer Institute, Amsterdam, the Netherlands., Dijkstra K; Division of Molecular Oncology & Immunology, the Netherlands Cancer Institute, Amsterdam, the Netherlands., Kluin RJC; Central Genomics Facility, the Netherlands Cancer Institute, Amsterdam, the Netherlands., Snaebjornsson P; Division of Pathology, the Netherlands Cancer Institute, Amsterdam, the Netherlands., Milne K; Trev and Joyce Deeley Research Centre, BC Cancer, Victoria, British Columbia, Canada., Nelson BH; Trev and Joyce Deeley Research Centre, BC Cancer, Victoria, British Columbia, Canada., Zijlmans H; Department of Gynecologic Oncology, the Netherlands Cancer Institute, Amsterdam, the Netherlands., Kenter G; Department of Gynecologic Oncology, the Netherlands Cancer Institute, Amsterdam, the Netherlands., Voest EE; Division of Molecular Oncology & Immunology, the Netherlands Cancer Institute, Amsterdam, the Netherlands.; Department of Medical Oncology, the Netherlands Cancer Institute, Amsterdam, the Netherlands., Haanen JBAG; Division of Molecular Oncology & Immunology, the Netherlands Cancer Institute, Amsterdam, the Netherlands.; Department of Medical Oncology, the Netherlands Cancer Institute, Amsterdam, the Netherlands., Schumacher TN; Division of Molecular Oncology & Immunology, Oncode Institute, the Netherlands Cancer Institute, Amsterdam, the Netherlands. t.schumacher@nki.nl.
Publikováno v:
Nature medicine [Nat Med] 2019 Jan; Vol. 25 (1), pp. 89-94. Date of Electronic Publication: 2018 Dec 03.
Autor:
Blank CU; Medical Oncology Department, Netherlands Cancer Institute, Amsterdam, The Netherlands. c.blank@nki.nl.; Division of Molecular Oncology & Immunology, Netherlands Cancer Institute, Amsterdam, The Netherlands. c.blank@nki.nl., Rozeman EA; Medical Oncology Department, Netherlands Cancer Institute, Amsterdam, The Netherlands.; Division of Molecular Oncology & Immunology, Netherlands Cancer Institute, Amsterdam, The Netherlands., Fanchi LF; Division of Molecular Oncology & Immunology, Netherlands Cancer Institute, Amsterdam, The Netherlands., Sikorska K; Department of Biometrics, Netherlands Cancer Institute, Amsterdam, The Netherlands., van de Wiel B; Department of Pathology, Netherlands Cancer Institute, Amsterdam, The Netherlands., Kvistborg P; Division of Molecular Oncology & Immunology, Netherlands Cancer Institute, Amsterdam, The Netherlands., Krijgsman O; Division of Molecular Oncology & Immunology, Netherlands Cancer Institute, Amsterdam, The Netherlands., van den Braber M; Division of Molecular Oncology & Immunology, Netherlands Cancer Institute, Amsterdam, The Netherlands., Philips D; Division of Molecular Oncology & Immunology, Netherlands Cancer Institute, Amsterdam, The Netherlands., Broeks A; Department of Pathology, Netherlands Cancer Institute, Amsterdam, The Netherlands., van Thienen JV; Medical Oncology Department, Netherlands Cancer Institute, Amsterdam, The Netherlands., Mallo HA; Medical Oncology Department, Netherlands Cancer Institute, Amsterdam, The Netherlands., Adriaansz S; Medical Oncology Department, Netherlands Cancer Institute, Amsterdam, The Netherlands., Ter Meulen S; Surgical Oncology Department, Netherlands Cancer Institute, Amsterdam, The Netherlands., Pronk LM; Department of Biometrics, Netherlands Cancer Institute, Amsterdam, The Netherlands., Grijpink-Ongering LG; Department of Biometrics, Netherlands Cancer Institute, Amsterdam, The Netherlands., Bruining A; Department of Radiology, Netherlands Cancer Institute, Amsterdam, The Netherlands., Gittelman RM; Adaptive Biotechnologies, Seattle, WA, USA., Warren S; NanoString Technologies, Inc., Seattle, WA, USA., van Tinteren H; Department of Biometrics, Netherlands Cancer Institute, Amsterdam, The Netherlands., Peeper DS; Division of Molecular Oncology & Immunology, Netherlands Cancer Institute, Amsterdam, The Netherlands., Haanen JBAG; Medical Oncology Department, Netherlands Cancer Institute, Amsterdam, The Netherlands.; Division of Molecular Oncology & Immunology, Netherlands Cancer Institute, Amsterdam, The Netherlands., van Akkooi ACJ; Surgical Oncology Department, Netherlands Cancer Institute, Amsterdam, The Netherlands., Schumacher TN; Division of Molecular Oncology & Immunology, Netherlands Cancer Institute, Amsterdam, The Netherlands. t.schumacher@nki.nl.
Publikováno v:
Nature medicine [Nat Med] 2018 Nov; Vol. 24 (11), pp. 1655-1661. Date of Electronic Publication: 2018 Oct 08.
Autor:
Dijkstra KK; Department of Molecular Oncology and Immunology, the Netherlands Cancer Institute, Antoni van Leeuwenhoek Hospital, 1066 CX Amsterdam, the Netherlands., Cattaneo CM; Department of Molecular Oncology and Immunology, the Netherlands Cancer Institute, Antoni van Leeuwenhoek Hospital, 1066 CX Amsterdam, the Netherlands., Weeber F; Department of Molecular Oncology and Immunology, the Netherlands Cancer Institute, Antoni van Leeuwenhoek Hospital, 1066 CX Amsterdam, the Netherlands., Chalabi M; Department of Molecular Oncology and Immunology, the Netherlands Cancer Institute, Antoni van Leeuwenhoek Hospital, 1066 CX Amsterdam, the Netherlands; Department of Gastroenterologic Oncology, the Netherlands Cancer Institute, Antoni van Leeuwenhoek Hospital, 1066 CX Amsterdam, the Netherlands., van de Haar J; Department of Molecular Oncology and Immunology, the Netherlands Cancer Institute, Antoni van Leeuwenhoek Hospital, 1066 CX Amsterdam, the Netherlands., Fanchi LF; Department of Molecular Oncology and Immunology, the Netherlands Cancer Institute, Antoni van Leeuwenhoek Hospital, 1066 CX Amsterdam, the Netherlands., Slagter M; Department of Molecular Oncology and Immunology, the Netherlands Cancer Institute, Antoni van Leeuwenhoek Hospital, 1066 CX Amsterdam, the Netherlands., van der Velden DL; Department of Molecular Oncology and Immunology, the Netherlands Cancer Institute, Antoni van Leeuwenhoek Hospital, 1066 CX Amsterdam, the Netherlands., Kaing S; Department of Molecular Oncology and Immunology, the Netherlands Cancer Institute, Antoni van Leeuwenhoek Hospital, 1066 CX Amsterdam, the Netherlands., Kelderman S; Department of Molecular Oncology and Immunology, the Netherlands Cancer Institute, Antoni van Leeuwenhoek Hospital, 1066 CX Amsterdam, the Netherlands., van Rooij N; Department of Molecular Oncology and Immunology, the Netherlands Cancer Institute, Antoni van Leeuwenhoek Hospital, 1066 CX Amsterdam, the Netherlands., van Leerdam ME; Department of Gastroenterologic Oncology, the Netherlands Cancer Institute, Antoni van Leeuwenhoek Hospital, 1066 CX Amsterdam, the Netherlands., Depla A; Department of Gastroenterology and Hepatology, EC Slotervaart Hospital, 1066 CX Amsterdam, the Netherlands., Smit EF; Department of Thoracic Oncology, the Netherlands Cancer Institute, Antoni van Leeuwenhoek Hospital, 1066 CX Amsterdam, the Netherlands., Hartemink KJ; Department of Surgery, the Netherlands Cancer Institute, Antoni van Leeuwenhoek Hospital, 1066 CX Amsterdam, the Netherlands., de Groot R; Department of Hematopoeisis, Sanquin Research, 1066 CX Amsterdam, the Netherlands., Wolkers MC; Department of Hematopoeisis, Sanquin Research, 1066 CX Amsterdam, the Netherlands; Landsteiner Laboratory, Amsterdam Medical Center, 1105 AZ Amsterdam, the Netherlands., Sachs N; Hubrecht Institute, University Medical Center Utrecht, 3584 CT Utrecht, the Netherlands., Snaebjornsson P; Department of Pathology, the Netherlands Cancer Institute, Antoni van Leeuwenhoek Hospital, 1066 CX Amsterdam, the Netherlands., Monkhorst K; Department of Pathology, the Netherlands Cancer Institute, Antoni van Leeuwenhoek Hospital, 1066 CX Amsterdam, the Netherlands., Haanen J; Department of Molecular Oncology and Immunology, the Netherlands Cancer Institute, Antoni van Leeuwenhoek Hospital, 1066 CX Amsterdam, the Netherlands., Clevers H; Hubrecht Institute, University Medical Center Utrecht, 3584 CT Utrecht, the Netherlands; Princess Maxima Center for Pediatric Oncology, 3584 CS Utrecht, the Netherlands; Oncode Institute, the Netherlands., Schumacher TN; Department of Molecular Oncology and Immunology, the Netherlands Cancer Institute, Antoni van Leeuwenhoek Hospital, 1066 CX Amsterdam, the Netherlands; Oncode Institute, the Netherlands., Voest EE; Department of Molecular Oncology and Immunology, the Netherlands Cancer Institute, Antoni van Leeuwenhoek Hospital, 1066 CX Amsterdam, the Netherlands. Electronic address: e.voest@nki.nl.
Publikováno v:
Cell [Cell] 2018 Sep 06; Vol. 174 (6), pp. 1586-1598.e12. Date of Electronic Publication: 2018 Aug 09.